Renaissance Technologies’s Liminal BioSciences Inc. Common Shares LMNL Stock Holding History

Renaissance Technologies’s Portfolio LMNL Stock Details LMNL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-3,850	Closed	-$13K	–	4512
2022 Q4	$13K	Sell	3,850 -989	-20%	-$4.52K	﹤0.01%	4024
2022 Q3	$20K	Sell	4,839 -1,801	-27%	-$8.93K	﹤0.01%	3901
2022 Q2	$34K	Buy	6,640 +3,112	+88%	+$20.2K	﹤0.01%	4061
2022 Q1	$35K	Sell	3,528 -9,213	-72%	-$86.4K	﹤0.01%	3956
2021 Q4	$139K	Buy	+12,741	New	+$191K	﹤0.01%	3621

Other funds holding LMNL

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

FDCDDQ

Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

ECM

Estabrook Capital Management New York $685M AUM 26.64% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

TWC

TD Waterhouse Canada Toronto, Ontario, Canada $33.7B AUM 35.49% 1-Year Est. Return

Renaissance Technologies's LMNL Position: Q1 2023 in Review

Renaissance Technologies sold out of Liminal BioSciences Inc. Common Shares (LMNL) in Q1 2023, closing a stake of 3,850 shares — an estimated $13K sold.

Renaissance Technologies first reported a position in LMNL in Q4 2021 and held it in 5 quarters. The position peaked at $139K in Q4 2021. 8 funds tracked by Wall St. Rank hold LMNL as of Q1 2023.

Renaissance Technologies reported no remaining Liminal BioSciences Inc. Common Shares position as of Q1 2023 after selling out during the quarter.
Renaissance Technologies sold 3,850 Liminal BioSciences Inc. Common Shares shares in Q1 2023, an estimated $13K.
Renaissance Technologies first reported a position in Liminal BioSciences Inc. Common Shares in Q4 2021 and held it in 5 quarters.
Renaissance Technologies's Liminal BioSciences Inc. Common Shares position peaked at $139K in Q4 2021.
8 funds tracked by Wall St. Rank held Liminal BioSciences Inc. Common Shares as of Q1 2023.

Based on Renaissance Technologies's 13F filing for Q1 2023, filed 12 May 2023.